News

Strategic plan for the National Medical Card Unit.

March' s self-management series 

We have been notified by Biogen that the production of the lyophilised form of Avonex (interferon beta-1a) BIO-SET which is used in the treatment of relapsing-remitting MS or clinically isolated syndrome, is being discontinued. This decision has been taken in view of the availability of alternative treatments and the diminishing market demand for the lyophilised form and is not due to any safety issues. This is the only presentation of Avonex that is being discontinued.

Save the date

This week Declan Groeger juxtaposes two very different topics, MS and Irish history, to give a unique perspective. It is who walks alongside us that can transform loss to victory. 

17th Annual General Meeting (56th AGM since MS Ireland’s foundation)

Apply now to become a Director 

In the second of our year-long series of debate blogs, Trevis talks about NOT taking an MS disease modifying therapy'.

Save the Date! 

In this week’s MS & Me blog, Niamh takes a look at why she decided to go on medication to manage her MS.